Johnson & Johnson (NYSE: JNJ) is a healthcare giant that sells over-the-counter products, pharmaceuticals, and medical devices. Its diversification makes it a core holding for many investors, including income investors who love its long track …
Johnson & Johnson (NYSE:JNJ) stock was down on Tuesday following the release of its earnings report for the first quarter of 2018. JNJ stock is down today despite the company’s strong earnings per share of $2.06 for the first quarter of the year.
... Johnson (JNJ.N) raised its sales forecast for the year on Tuesday but kept its outlook for full-year profit unchanged, disappointing investors and sending its shares down 1.6 percent. The healthcare conglomerate, whose stock had …
Information contained on this page is provided by an independent third-party content provider. Frankly and this Site …
Johnson & Johnson is a blue chip dividend aristocrat When I think of Johnson & Johnson (JNJ), I can’t help but think of high quality. Many refer to the stock as a health care mutual fund, with its broad diversification in the health care industry.
Johnson & Johnson (NYSE: JNJ) stock first traded back in 1944. For the first 58 years of the company's existence, it was privately held by the Johnson family. J&J stock has been a big winner throughout the years, but never more so than …